We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Tissue-Imaging Technology Enables Real-Time Diagnostics

By LabMedica International staff writers
Posted on 04 Jul 2018
Print article
Image: A tissue-imaging microscope has been developed that can image living tissue in real time and molecular detail, allowing them to monitor tumors and their environments as cancer progresses (Photo courtesy of Professor Stephen Boppart).
Image: A tissue-imaging microscope has been developed that can image living tissue in real time and molecular detail, allowing them to monitor tumors and their environments as cancer progresses (Photo courtesy of Professor Stephen Boppart).
A new microscope system can image living tissue in real time and in molecular detail, without any chemicals or dyes. The system is called simultaneous label-free autofluorescence multi-harmonic microscopy (SLAM).

The system uses precisely tailored pulses of light to simultaneously image with multiple wavelengths. This enables scientists to study concurrent processes within cells and tissue, and could give those studying cancer a new tool for tracking tumor progression and physicians new technology for tissue pathology and diagnostics.

Scientists at the University of Illinois at Urbana-Champaign, Urbana, IL, USA) designed an optical imaging platform that performs simultaneous label-free autofluorescence-multiharmonic (SLAM) microscopy, featuring fast epi-detection of nicotinamide adenine dinucleotide (NADH) from three-photon autofluorescence (3PAF) and simultaneous, and efficient acquisition of autofluorescence (FAD) from two-photon autofluorescence (2PAF), combined with non-centrosymmetric structures from second-harmonic generation (SHG) and interfacial features from third-harmonic generation (THG).

The team saw that the cells near the mammary tumors in rats had differences in metabolism and morphology, indicating that the cells had been recruited by the cancer. In addition, they observed surrounding tissues creating infrastructure to support the tumor, such as collagen and blood vessels. They also saw communication between the tumor cells and the surrounding cells in the form of vesicles, tiny transport packages released by cells and absorbed by other cells. The authors concluded that they had demonstrated the versatility and efficiency of SLAM microscopy for tracking cellular events in vivo, and are a major enabling advance in label-free intravital microscopy (IVM).

Stephen A. Boppart, MD, PhD, a professor and head of the Biophotonics Imaging Laboratory, and senior author of the study, said, “With advances in microscopy techniques such as ours, we hope to change the way we detect, visualize and monitor diseases that will lead to better diagnosis, treatments and outcomes.” The study was published on May 29, 2018, in the journal Nature Communications.

Related Links:
University of Illinois at Urbana-Champaign

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.